Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
About
Responding to the needs of the scientific community to bolster a vibrant and sustainable research workforce, the Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has incorporated additional flexibilities for institutional training programs serving the mission interests of non-malignant kidney, urologic, and hematologic diseases, encompassing both adult and pediatric conditions. The purpose of this notice of funding opportunity is to invite applications for Institutional Network Awards (U2C-TL1) to recruit, train, and retain the next generation of researchers and provide them with the coordinated support, resources, and networks they need to succeed and lead. To maximize integration and promote a highly connected trainee community, institutions are invited to submit a single, unified U2C-TL1 application. Representation across all kidney, urologic, and hematologic disciplines is not expected or required. If feasible, applications may include multiple departments within and across institutions. It is expected that each U2C-TL1 award will actively participate in the Kidney, Urology and Hematology Research-Training Network (KUHR-TN), a nationwide coalition of individual U2C-TL1 awards.
The Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-TL1) is a federal grant program designed to strengthen the research workforce in non-malignant kidney, urologic, and hematologic diseases. Administered by the Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), this program supports institutions in recruiting, training, and retaining the next generation of researchers across both adult and pediatric conditions. Eligible institutions can submit unified applications that may span multiple departments within and across institutions, providing coordinated support, resources, and networks to trainees. Award recipients are expected to actively participate in the Kidney, Urology and Hematology Research-Training Network (KUHR-TN), a nationwide coalition fostering a highly connected research community. This program is ideal for research institutions seeking to build sustainable training infrastructure and develop competitive researchers in kidney, urologic, and hematologic disease research. Institutions should note that clinical trial activities are not permitted under this award mechanism.
Funding Facts
● Applications openDeadline
May 26, 2028
Award Amount
Up to $2.1M
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Grant Amount
Up to $2.1M
Deadline
2028-05-26
Grant Type
federal
Application Cycle
Annual
Best For
Research institutions training the next generation of kidney, urologic, and hematologic disease researchers
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH w
Frequently Asked Questions
Who is eligible for Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)?
U.S. domestic institutions are eligible to apply. Foreign organizations and non-domestic components of U.S. organizations are not eligible, though foreign components within U.S. organizations may be permitted under NIH Grants Policy. For complete eligibility requirements, refer to Section III of the Notice of Funding Opportunity (NOFO) on the official NIH website or contact the NIDDK directly.
How much funding does Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed) provide?
Award amounts range from N/A to $2,100,000. Actual funding varies based on institutional needs, scope of the proposed training program, and current budget availability. Consult the most recent NOFO for specific funding limits applicable to your application cycle.
How do I apply for Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)?
Institutions submit a single, unified U2C-TL1 application through the official NIH grant submission system. Applications should describe your institutional training program, trainee recruitment and retention strategies, and integration plans with the Kidney, Urology and Hematology Research-Training Network (KUHR-TN). Visit the NIH and NIDDK websites for detailed application instructions, forms, and the complete NOFO.
What can Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed) funding be used for?
Funding supports institutional training programs focused on non-malignant kidney, urologic, and hematologic diseases (both adult and pediatric). Resources should support trainee recruitment, training, and retention, as well as provide coordinated support and networks to develop future research leaders. Clinical trial activities are not permitted. Detailed allowable uses are outlined in the NOFO.
Last updated: July 5, 2026